Address: Beijing's xizhimen south street, xicheng district
The British garden 1 floor. Room 824
Zip code: 100035
Telephone: 010-58562339
Fax: 010-58562339
Email address: cngjzj@163.com
Web site (click on the url link directly left) :
http://www.cngjzj.com/
Blog (click on the url link directly left) :
http://blog.sina.com.Cn/CNGJZJ
To xizhimen south street, xicheng district building to the British garden route
L airport line 1
Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.
L airport line 2
From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.
L bus subway near:
106 bus GuanYuan: 107 road, express way
Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road
Che zhuang: subway line two
Xizhimen subway: metro line 2
Buses and attempts: 107 road, 118 road, 701 road
Buses and north zhuang: 209 road, 375 road, 392 road
2016年02月29日
复制链接
打印
大 中 小
Food: drug safety administration priority has significant clinical value for examination and approval of drugs
2016-02-29 10:02
The Chinese news
Food drug safety administration has issued a "about addressing drug registration for priority review backlog of examination and approval opinions". "Opinions" pointed out that has significant clinical value, or to fight AIDS, tuberculosis, viral hepatitis and rare diseases, malignant tumor, children with drugs, aged and multiple disease has obvious clinical advantages, as well as the urgent clinical needs, the shortage of market for drug registration, will be priority review for approval.
"Opinions" pointed out that has significant clinical value for drug registration including not publicly listed company in China sales of innovative drugs, in the prevention and control of major diseases with clear clinical orientation of traditional Chinese medicine (including national medicine), and the applicant in the United States, the European Union synchronous application and are allowed to carry out drug clinical trial of new drug clinical trials for 7 kinds of situations. For treating severe life-threatening illness and there is no effective treatment, the clinical demand is of great significance to solve the new drugs, the applicant may apply for face to face communication with human medicinal center, review staff will arrange meeting to exchange views in 10 days. If according to the early clinical trial data, can reasonably predict or determine its clinical benefit and the existing treatment has obvious advantages, allow the complete phase Ⅲ confirmed conditional approal before clinical trials. (reporter Chen haibo)
Your position is：
